Pure Global

POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 50 MG SOLUTION FOR INFUSION, 1 PIECE - Turkey License 843787b8dd6727b5032f6cc9f7d26a1e

Access comprehensive regulatory information for POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 50 MG SOLUTION FOR INFUSION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 843787b8dd6727b5032f6cc9f7d26a1e with license number 2022/336and contains active ingredient Anidulafungin. The license is held by DEVA HOLDฤฐNG A.ลž..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
843787b8dd6727b5032f6cc9f7d26a1e
License Details
Turkey SFDA License: 843787b8dd6727b5032f6cc9f7d26a1e
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 50 MG SOLUTION FOR INFUSION, 1 PIECE
TR: DULAFUX 50 MG ฤฐNFรœZYONLUK ร‡ร–ZELTฤฐ HAZIRLAMADA KULLANILACAK KONSANTRE ฤฐร‡ฤฐN TOZ, 1 ADET
Pharmaceutical Product

License Details

843787b8dd6727b5032f6cc9f7d26a1e

2022/336

8699525798541

J02AX06

License Holder Information

Active Ingredient

Anidulafungin

License Information

Jun 22, 2022